PARIS, May 12 (Reuters) - U.S. pharmaceutical and healthcare giant Pfizer announced on Sunday a 500 million-euro ($538 million) investment in France for research and development, ahead of the start of this year's annual 'Choose France' business summit. ($1 = 0.9286 euros) (Reporting by Sudip Kar-Gupta and Elizabeth Pineau; Editing by Hugh Lawson)
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
29.04 USD | -1.89% | +0.76% | +1.22% |
03:34pm | Pfizer: initiative against antibiotic resistance in Malawi | CF |
03:28pm | The market is good to go until Nvidia’s next quarterly results |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.87% | 168B | |
+38.83% | 723B | |
+33.86% | 595B | |
-2.72% | 369B | |
+20.20% | 332B | |
+2.34% | 282B | |
+16.83% | 244B | |
+9.47% | 208B | |
-4.91% | 205B | |
+6.93% | 166B |
- Stock Market
- Equities
- PFE Stock
- News Pfizer, Inc.
- Pfizer announces 500 million euros investment in France